|
|
Vol. 26.13 – 28 July, 2025
|
|
|
|
|
|
|
|
This Phase II trial assessed CD7 CAR T-cells derived from previous transplant or newly HLA-matched donors for relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. [Blood]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
Scientists constructed a single-cell atlas of diverse cancers to identify cellular subsets expressing FASLG, the gene encoding FAS-ligand.
[Nature Cancer]
|
|
|
|
|
|
A 3D micrometastases model was developed to mimic key microenvironmental cues, enabling in vitro evaluation of CAR T cell immunotherapy.
[Advanced Science]
|
|
|
|
|
|
Investigators successfully treated a 36-year-old patient with severe autoimmune encephalitis using CAR T cells.
[Med]
|
|
|
|
|
|
Leveraging hiPSC-derived retinal organoids, retinal pigmented epithelial cells, and the retina-on-chip system, scientists established an in vitro neuronal ceroid lipofuscinosis type 2 (CLN2) model that recreates the principal histological hallmarks.
[Cell Reports Medicine]
|
|
|
|
|
|
Researchers reported a gene therapy strategy to reprogram the tumor microenvironment and revive the therapeutic potential of CAR T cells by leveraging tumor-infiltrating macrophages as vehicles for tumor-targeted gene-based delivery of immune-activating cytokines.
[Molecular Therapy]
|
|
|
|
|
|
By analyzing the expression of B7-H3 in colorectal cancer (CRC) tissue and cell lines using immunohistochemistry and flow cytometry, respectively, the authors identified B7-H3 as a potential target in CRC.
[British Journal of Cancer]
|
|
|
|
|
|
Investigators constructed a recombinant Newcastle disease virus expressing human CCL19 and evaluated its therapeutic efficacy alongside doxycycline-inducible CAR T cells in an orthotopic lung cancer mouse model.
[Journal of Immunotherapy of Cancer]
|
|
|
|
|
|
Using convection-enhanced delivery of AAV9 encoding green fluorescent protein, scientists mapped the extensive neural connectivity from the olfactory bulb to key memory-related brain regions. [Gene Therapy]
|
|
|
|
|
|
|
|
Gene therapy has traditionally targeted rare Mendelian disorders and cancer. However, gene transfer may also be harnessed to treat common, complex diseases, delivering therapeutic cDNAs into patients who are genetically unremarkable.
[Molecular Therapy]
|
|
|
|
|
|
By comparing the mechanisms of lymphocyte activation by CARs vs. T cell receptors, scientists discuss how these chimeric constructs induce a stimulation characterized by un-orchestrated, incomplete, or impaired signaling events that in turn could explain some of their shortcomings. [Journal of Translational Medicine]
|
|
|
|
|
|
|
|
Elpis Biopharmaceuticals announced the signing of a Memorandum of Understanding with the National Cancer Centre Singapore. The partnership will support collaborative cell therapy research and clinical trials for the treatment of a variety of cancers. [Elpis Biopharmaceuticals (PR Newswire)]
|
|
|
|
|
|
|
|
September 8-12, 2025 Suzhou, China
|
|
|
|
|
|
|
|
|
|
|
Universitätsklinikum Tübingen – Tübingen, Germany
|
|
|
|
|
|
|
Dana-Farber Cancer Institute – Boston, Massachusetts, United States
|
|
|
|
|
|
|
Dana-Farber Cancer Institute – Boston, Massachusetts, United States
|
|
|
|
|
|
|
Salk Institute for Biological Studies – La Jolla, California, United States
|
|
|
|
|
|
|
University of British Columbia Department of Surgery – Vancouver, British Columbia, Canada
|
|
|
|
|
|